Dr. Mohammed Rabiul Hosen, a member of the TRR259, has now received such a research grant of € 50,000 for his research project for 2021.
Dr. Hosen together with his team involved in research on cardiovascular disease (CVD), from investigating the underlying molecular mechanisms of pathogenesis in coronary heart diseases (CHDs) to the development of holistic RNA-based therapeutic approaches for the diagnosis ("Liquid Biopsies") and treatment of multifactorial CVDs. Since his PhD research at the Inst. of Cardiovascular Regeneration, Goethe University Frankfurt, he has been working on the development of RNA-based cardiovascular biomarkers/therapies by focusing on different CVDs, including atherosclerosis and its sequelae, and implementing in vitro and in vivo models (myocardial infarction, atherosclerosis, aortic valve stenosis, and heart failure).
Congratulations and good luck with your work.